Objective
Our novel OMiProbe (Optical Fibre Micro Probe) is an optical device that allows quantitative cellular processes studies, even inside a single cell, and carries the disruptive potential for real-time, ‘in-vivo’ cancer diagnosis. At the current stage of development, with a diameter of less than 6 µm and a biologically active (antibodies) coating applied at the tip of the fibre optic probe, we are able to perform cellular level spectral identification of certain types of carcinomas, specifically breast cancer. (Carcinomas type of cancer comprise 80% to 90% of all cancers)
The state of the art methods of cancer diagnosis require cutting/extracting tissue sample in a process called a biopsy, and consequently make non-destructive and live observations impossible. We believe OMiProbe technology offers an alternative to the destructive process of biopsy, and presents a safe, minimally invasive method for instantaneous cancer diagnosis and identification. With the OMiProbe, tissue may be examined ‘in vivo’ by insertion of the needle-sized OMiProbe into the suspected tissue, on live patients during standard medical examination, or during surgery.
For better understanding and curing of cancer, early detection and diagnosis play a critical role. Cancer is in many cases treatable, and early detection increases the chance of cure substantially. However, it is not sufficient to define if the patient is ill or not. A more careful and prompt identification and examination of ill cells of the patient are needed to determine optimal treatment and approach. Today, such studies are difficult to quantify and impossible to realize non-destructively and in real-time. However, InPhoTech’s OMiProbe may allow to do just that.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.
- medical and health sciences health sciences public health
- medical and health sciences clinical medicine surgery
- medical and health sciences clinical medicine oncology breast cancer
- social sciences economics and business economics sustainable economy
- natural sciences physical sciences optics fibre optics
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
H2020-EU.2.1.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT)
MAIN PROGRAMME
See all projects funded under this programme -
H2020-EU.2.3.1. - Mainstreaming SME support, especially through a dedicated instrument
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
SME-1 - SME instrument phase 1
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) H2020-SMEInst-2016-2017
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
05-850 Ołtarzew
Poland
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.